Results 221 to 230 of about 41,578 (284)

Exposure of Laboratory Workers to Francisella tularensis despite a Bioterrorism Procedure

, 2002
Daniel S. Shapiro, Donald R. Schwartz
openalex   +1 more source

Development of a Recombinant Fusion Vaccine Candidate Against Lethal Clostridium botulinum Neurotoxin Types A and B. [PDF]

Vaccines (Basel)
Choi ES, Pyo SW, Kim SH, Jeon JH, Rhie GE, Yun MR, Yi H, Chung YS.   +7 more
europepmc   +1 more source

Bacteriologic and Genomic Investigation of Bacillus anthracis Isolated from World War II Site, China. [PDF]

Emerg Infect Dis
Wu Y, Yuan Y, Yuan B, Li J, Wang J, Cui Y.   +5 more
europepmc   +1 more source

The Importance of Biosecurity in Emerging Biotechnologies and Synthetic Biology. [PDF]

Avicenna J Med Biotechnol
Soleimani Sasani M.
europepmc   +1 more source

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E. [PDF]

Front Immunol
Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.   +5 more
europepmc   +1 more source

Editorial: Global excellence in bacteriology: Central and South America. [PDF]

Front Cell Infect Microbiol
Navarro-Garcia F, Brocchi M, Cataldi AA.
europepmc   +1 more source

rLVS Δ<i>capB</i>/Yp F1-V single vector platform vaccine expressing <i>Yersinia pestis</i> F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. [PDF]

Hum Vaccin Immunother
Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA.   +3 more
europepmc   +1 more source

Biological Safety Issues [PDF]

, 2014
Kabashna, Veronica, Kostrytska, S.I., Kovrov, O.S.   +2 more
core  

Responsible AI in biotechnology: balancing discovery, innovation and biosecurity risks. [PDF]

Front Bioeng Biotechnol
Wheeler NE.
europepmc   +1 more source